TrialPloS one2022

Feasibility and preliminary efficacy for morning bright light therapy to improve sleep and plasma biomarkers in US Veterans with TBI. A prospective, open-label, single-arm trial.

Jonathan E Elliott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.